38 results
425
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Business combination disclosure
6:02am
each had a direct or indirect material interest in the transaction. As a result, pursuant to AMTI’s Corporate Governance Guidelines, Audit Committee
8-K
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Other Events
6:01am
had a direct or indirect material interest in the transaction. As a result, pursuant to AMTI’s Corporate Governance Guidelines, Audit Committee Charter
425
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Business combination disclosure
4:28pm
to such reports.
(f) The Company is in compliance in all material respects with all current listing and corporate governance requirements … is in compliance in all material respects with all current listing and corporate governance requirements of the Nasdaq. Parent Common Stock
8-K
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
to such reports.
(f) The Company is in compliance in all material respects with all current listing and corporate governance requirements … is in compliance in all material respects with all current listing and corporate governance requirements of the Nasdaq. Parent Common Stock
8-K
EX-10.1
xwmw3lvafo8 ivk
25 Jun 21
Departure of Directors or Certain Officers
4:03pm
424B4
yy37xj6 sch
11 Dec 20
Prospectus supplement with pricing info
1:38pm
424B4
8gpy kcuc3icaw
11 Dec 20
Prospectus supplement with pricing info
12:00am